Davis Jonathan D, Olsen Margaret A, Bommarito Kerry, LaRue Shane J, Saeed Mohammed, Rich Michael W, Vader Justin M
Knight Cardiovascular Institute, Oregon Health & Science University, Portland.
Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, Mo; Division of Public Health Sciences, Washington University School of Medicine, Saint Louis, Mo.
Am J Med. 2017 Jan;130(1):93.e9-93.e28. doi: 10.1016/j.amjmed.2016.07.030. Epub 2016 Aug 31.
Thirty-day readmission following heart failure hospitalization impacts hospital performance measures and reimbursement. We investigated readmission characteristics and the magnitude of 30-day hospital readmissions after hospital discharge for heart failure using the Healthcare Cost and Utilization Project State Inpatient Databases (SID).
Adults aged ≥ 40 years hospitalized with a primary discharge diagnosis of heart failure from 2007-2011 were identified in the California, New York, and Florida SIDs. Characteristics of patients with and without 7-, 8 to 30-, and 30-day readmission, and primary readmission diagnoses and risk factors for readmission were examined.
We identified 547,068 patients with mean age 74.7 years; 50.7% were female, and 65.4% were White. Of 117,123 patients (21.4%) readmitted within 30 days (median 12 days), 69.7% had a non-heart failure primary readmission diagnosis. Patients with 30-day readmissions more frequently had a history of previous admission with heart failure as a secondary diagnosis, fluid and electrolyte disorders, and chronic deficiency anemia. There were no significant clinical differences at baseline between those patients whose first readmission was in the first 7 days after discharge vs in the next 23 days. The most common primary diagnoses for 30-day non-heart failure readmissions were other cardiovascular conditions (14.9%), pulmonary disease (8.5%), and infections (7.7%).
In this large all-payer cohort, ∼70% of 30-day readmissions were for non-heart failure causes, and the median time to readmission was 12 days. Future interventions to reduce readmissions should focus on common comorbid conditions that contribute to readmission burden.
心力衰竭住院后的30天再入院情况会影响医院绩效指标和报销。我们使用医疗成本和利用项目州住院数据库(SID)调查了心力衰竭出院后30天内再入院的特征及规模。
在加利福尼亚州、纽约州和佛罗里达州的SID中识别出2007年至2011年因心力衰竭作为主要出院诊断而住院的40岁及以上成年人。检查了有和没有7天、8至30天以及30天再入院患者的特征、初次再入院诊断以及再入院的危险因素。
我们识别出547,068例患者,平均年龄74.7岁;50.7%为女性,65.4%为白人。在30天内再入院的117,123例患者(21.4%)中,69.7%的初次再入院诊断并非心力衰竭。30天再入院的患者更常伴有心力衰竭作为次要诊断的既往住院史、液体和电解质紊乱以及慢性缺铁性贫血。首次再入院在出院后前7天内的患者与接下来23天内的患者在基线时无显著临床差异。30天非心力衰竭再入院最常见的主要诊断为其他心血管疾病(14.9%)、肺部疾病(8.5%)和感染(7.7%)。
在这个大型的全付费者队列中,约70%的30天再入院是由非心力衰竭原因导致的,再入院的中位时间为12天。未来减少再入院的干预措施应聚焦于导致再入院负担的常见合并症。